Navigation Links
Blood test for pregnant women could predict risk of having dangerously small babies
Date:6/21/2012

Researchers from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa (uOttawa) have found a protein in the blood of pregnant women that can predict if they are likely to have a fetus that doesn't grow properly, and thus has a high risk of stillbirth and long-term health complications. The research, led by Dr. Andre Gruslin, could lead to a widely available blood test and could help develop ways for improving the outcomes of women and their children who face this risk estimated to be as many as one of every 20 pregnancies.

Dr. Gruslin's study, published in the Journal of Clinical Endocrinology and Metabolism, focuses on a protein called Insulin Growth Factor Binding Protein 4 (IGFBP-4). While this protein has been linked to pregnancy before, this study is the first to demonstrate its important role in human pregnancy complications. A key part of the study involved examining IGFBP-4 levels in first trimester blood samples from women who participated in a large study of pregnancies and newborns called the Ottawa and Kingston (OaK) birth cohort.

Dr. Gruslin found that women with high levels of IGFBP-4 were 22 times more likely to give birth to tiny babies (defined as the smallest five per cent by weight for their gestational age), than women with normal levels of IGFBP-4. This part of the study involved a total of 72 women half with tiny babies and half with normal weight babies.

"Usually, we don't find out until later in a pregnancy that a fetus isn't growing properly, but this test can tell us in the first trimester if there's likely to be a problem," said Dr. Gruslin, a Scientist at OHRI, High Risk Obstetrician at The Ottawa Hospital and Professor in the Faculty of Medicine at uOttawa. "By identifying these high-risk pregnancies early on, we will be able to monitor these women more closely and hopefully help them deliver a healthier baby."

The IGFBP-4 blood test is still experimental, but Dr. Gruslin hopes to develop a refined version that could be made available to all pregnant women within the next couple of years. She also hopes that her studies on IGFBP-4 could lead to new approaches that would improve fetal growth in high-risk pregnancies. This condition, called Fetal Growth Restriction or Intrauterine Growth Restriction, is thought to affect three to five per cent of all pregnancies, and cause close to half of all stillbirths. Babies born with this condition also have a higher risk of developing serious health complications in infancy and childhood, as well as chronic diseases such as hypertension and diabetes in adulthood.

Fetal Growth Restriction is thought to occur when the placenta, which provides nourishment and oxygen for the fetus, doesn't grow properly. Research by Dr. Gruslin and others suggests that IGFBP-4 blocks the activity of a key placental growth hormone called IGF-II, which results in poor growth of the placenta and fetus. Dr. Gruslin and her team are already testing a number of strategies for targeting IGFBP-4 to improve placental and fetal growth.


'/>"/>
Contact: Jennifer Ganton
jganton@ohri.ca
613-798-5555 x73325
Ottawa Hospital Research Institute
Source:Eurekalert

Related medicine news :

1. Infection Might Raise Blood Clot Risk for Older Adults: Study
2. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
3. Common Blood Pressure Drug Safe for Heart Failure: Study
4. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
5. High Blood Pressure May Be Especially Lethal for Blacks
6. Changes in gene expression may help explain high blood pressure in pregnancy
7. Researchers Develop Blood Test for Depression
8. Naturopathic care can improve blood sugar, mood in diabetes
9. Diabetes Groups Issue New Guidelines on Blood Sugar
10. Exercise May Help Patients With High Blood Pressure Live Longer
11. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2020)... ... July 02, 2020 , ... ... Outstanding Safety Professional of the Year Award to Eric Simmons of Temecula, California. ... than 250 nominations. Simmons, who holds a master’s degree in occupational safety and ...
(Date:7/2/2020)... ... July 02, 2020 , ... The ... offices for non-emergency work. In conjunction with the American Dental Association and Centers ... practices in mid-May. , Due to safety concerns, the announcement sparked hesitancy ...
(Date:7/1/2020)... , ... July 01, 2020 , ... ... and botanically-derived terpenes, has officially released its new terpene infused product line ... way for consumers to enjoy cannabis terpene profiles and flavors worldwide. , “We’ve ...
(Date:7/1/2020)... ... 2020 , ... The Society to Improve Diagnosis in Medicine ... University of Massachusetts Medical School- Baystate and Ann Gaffey, RN, MSN, CPHRM, DFASHRM, ... Directors. Dr. Salvador and Ms. Gaffey’s service began in May and the initial ...
(Date:6/28/2020)... (PRWEB) , ... June 26, 2020 , ... ... call for participation in the revision and redesignation of the ANSI/APSP/ICC-7 2013 American ... Tubs, and Catch Basins. PHTA is seeking member participation on the PHTA-7 Standard ...
Breaking Medicine News(10 mins):
(Date:7/2/2020)... LAKE CITY (PRWEB) , ... July 02, 2020 , ... ... for interactive client projects and four Omni Awards for visually compelling compliance training ... continues to strive to meet and exceed client and industry expectations as a digital ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... hosting a four-part health series on its live agent Town Halls, furthering its ... and work. The series includes special guests and Realty ONE Group leadership discussing ...
(Date:7/1/2020)... (PRWEB) , ... July 01, 2020 , ... ... of The International Business Awards® is Tuesday, July 28. , ... awards competition. In 2019 the competition attracted more than 4,000 nominations from ...
Breaking Medicine Technology: